BRISTOL MYERS SQUIBB FDA Approval ANDA 061605

ANDA 061605

BRISTOL MYERS SQUIBB

FDA Drug Application

Application #061605

Application Sponsors

ANDA 061605BRISTOL MYERS SQUIBB

Marketing Status

Discontinued001
Discontinued002

Application Products

001TABLET;ORALEQ 250MG BASE0ETHRIL 250ERYTHROMYCIN STEARATE
002TABLET;ORALEQ 500MG BASE0ETHRIL 500ERYTHROMYCIN STEARATE

CDER Filings

BRISTOL MYERS SQUIBB
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 61605
            [companyName] => BRISTOL MYERS SQUIBB
            [docInserts] => ["",""]
            [products] => [{"drugName":"ETHRIL 250","activeIngredients":"ERYTHROMYCIN STEARATE","strength":"EQ 250MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"ETHRIL 500","activeIngredients":"ERYTHROMYCIN STEARATE","strength":"EQ 500MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ETHRIL 250","submission":"ERYTHROMYCIN STEARATE","actionType":"EQ 250MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"ETHRIL 500","submission":"ERYTHROMYCIN STEARATE","actionType":"EQ 500MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.